Roche Diagnostics Corporation and NMS Management Services Working to Fight Drugs in Florida School

Indianapolis, Indiana - November 11, 2002 - NMS Management Services, of Delray Beach, Fla. has chosen Roche Diagnostics Corporation, of Indianapolis, Ind., products to provide drugs of abuse screening to school systems in the state of Florida.

On June 27, 2002, the U.S. Supreme Court upheld a ruling that allows public schools to randomly drug test students involved in extracurricular activities. This has given the green light to public schools across the country to use random drug testing procedures. David Evans, Drug-Free Schools Coalition, of Flemington, NJ, said of the ruling, "It is a victory for common sense and our schools will be safer as a result."

NMS Management Services, Inc., is a full-service drug-screening company, founded in 1988 by Elaine Taule. As a mother of six children, 14 years ago Taule educated herself on the signs and symptoms of substance abuse. That education flourished into a successful business that now has more than 1,000 clients nationwide and a staff of 20. NMS designs drug screening programs tailored to meet each client's specific needs.

"NMS Management Services was born out of the desire to see teenagers and schools drug-free and safe. We administer drug-screening programs and help develop policy, procedures and protocol. Random drug testing would help prevent drug abuse by teenagers at a time when adolescent drug use in on the rise," says Elaine Taule, President of NMS Management Services, Inc.

"NMS has chosen the drug-testing products offered by Roche Diagnostics, the leading U.S. diagnostics company, because Roche brings more than 30 years of experience and corporate commitment to drugs-of-abuse screening technology. Roche drug-testing products are recognized nationwide. However, we chose Roche products, not only because Roche is a market leader, but because Roche offers the most comprehensive training, educational support, product support against legal challenges, and 24-hour service to their customers."

"We are very pleased to work with NMS in this worthwhile endeavor - helping schools ensure a drug-free environment," said Jackie Pirone, Marketing Manager, Roche Diagnostics. "Like NMS, we are interested in assisting school systems in preventing, deterring, and detecting drug use. Drug testing is a strong incentive for students to avoid any involvement with drugs."

For more information about Roche Diagnostics' variety of products and services for drugs-of-abuse testing, please visit the Roche Diagnostics Drugs-of-Abuse Testing website at: http://www.onsite-dat.com

About NMS Management Services, Inc.:

NMS Management Services, Inc. is a full-service drug-screening company. Affiliations with Certified Laboratories/Employee Assistance Programs (EAP)/Medical Review Officers (MRO), and a collection site network of more than 1,400, makes NMS a front-runner in the substance-abuse testing industry. NMS also offers professional paramedical services for life and health insurance companies.

NMS Management Services, Inc., headquarters are located in Delray Beach, Florida, telephone (800) 269-0502. The website is www.nms123.com.

About Roche Diagnostics Corporation:

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-oriented healthcare groups. The company's two core businesses in pharmaceuticals and diagnostics provide innovative products and services that address prevention, diagnosis, and treatment of diseases, thus enhancing people's health and quality of life. The two core businesses employ about 57,000 employees worldwide. Roche's Diagnostics Division, the world leader in invitro diagnostics with a uniquely broad product portfolio, supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals, and laboratories worldwide. For further information, please visit our websites www.roche.com and www.roche-diagnostics.com.

Roche Diagnostics' North American headquarters are in Indianapolis, IN. The Diagnostics Division is comprised of five business units: Applied Science, Molecular Diagnostics, Centralized Diagnostics, Diabetes Care, and Near Patient Testing. The Near Patient Testing business unit produces drugs-of-abuse testing devices, including OnTrak TesTcup®, and OnTrak TesTstik™ products, and distributes the OnSite® Alcohol device. The DAT website is www.onsite-dat.com.

ONTRAK TESTCUP and ONTRAK TESTSTIK are trademarks of a Member of the Roche Group. OnSite is a trademark of Ansys Technology Inc.